课题基金 / 基金详情

Design of sustained release liquid formulations using thereto-responsible intelligent polymers and nanoparticles

Design of sustained release liquid formulations using thereto-responsible intelligent polymers and nanoparticles
使用相应的智能聚合物和纳米颗粒设计缓释液体制剂
批准号:
15500321
负责人:
MIYAZAKI Shozo
金额:
$1.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MIYAZAKI Shozo的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.The purpose of this study was concerned with the development of sustained release liquid formulatios for the elderly and the infant using thermo-responsible gelation of Pluronic F-127 and xyloglucan or ionic-responsible gelation of Pectin. All of which were designed to be administered in liquid dosage forms and to form gels in situ in the acidic environment of stomach. We have demonstratated the potential as sustained release vehicles of gels formed in situ following the oral administration of aqueous solutions of these intelligent polymers by in vitro and in vivo studies. The viscosities of all of these formulations were sufficiently low that no difficulties with swallowing were envisaged. 2.An oral drug delivery could possibly be improved if nanoparticle carrier system was incorporated into an intelligent polymer liquid formulation. In this study, poly n-butylcyanoacrylate(PNBCA) nanocapsules of indomethacin were prepared by interfacial polymerization. The physicochemical characterization of the PNBCA nanocapsules was performed by measuring the drug content by HPLC and analyzing the particle size using SEM. The drug loading results indicated that 76.6% of indomethacin was loaded onto the F'NBCA nanocapsules, the average particle size was 188 nm. The presented data expected that indomethacin loaded PNBCA nanocapsules could improve the oral drug delivery compared to a conventional gel formulation. This might be due to their ultra fine particle size and their hydrophilic and hydrophobic surface characteristics.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Oral sustained delivery of theopylline and cimetidine from in situ gelling pectin formulations in rabbits ectin formulations in rabbits
兔体内原位胶凝果胶制剂中茶茶碱和西咪替丁的口服持续递送 ectin 制剂在兔体内
DOI: --
发表时间: 2005
期刊: Drug Develop.Indus.Pharm 31(in press)
影响因子: --
作者: [W.Kubo, S.Miyazaki, D.Attwood]
通讯作者: D.Attwood
英国におけるDDSの開発の動向(その4)
英国DDS发展趋势(第4部分)
DOI: --
发表时间: 2005
期刊: PHARM TECH JAPAN 21
影响因子: --
作者: [宮崎正三, D.Attwood]
通讯作者: D.Attwood
Some new aspects on development of drug delivery system in Great Britain (no.4)
英国药物输送系统发展的一些新情况(第4号)
DOI: --
发表时间: 2005
期刊: PHARM TECH JAPAN 21
影响因子: --
作者: [Shozo Miyazaki, David.Attwood]
通讯作者: David.Attwood
DOI: --
发表时间: 2005
期刊: Int.J.Pharm 297
影响因子: --
作者: [S.Miyazaki, W.Kubo, K.Itoh, Y.Konno, M.Fuiiwara, M.Dairaku, M.Togashi, R.Mikami, David Attwood]
通讯作者: David Attwood
Application of Ultrasound to Drug Therapy ; Transdermal Therapeutic System Using Pulsed Ultrasound
  • 批准号:
    06672153
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.28万
  • 财政年份:
    1994
  • 负责人:
    MIYAZAKI Shozo
  • 依托单位: